Osteoporosis Screening - extended

The Osteoporosis Screening (Extended) is a comprehensive laboratory profile designed to evaluate bone metabolism and identify factors associated with decreased bone mineral density. The profile includes markers of calcium and phosphorus metabolism, bone remodeling, as well as hormonal and metabolic parameters relevant to skeletal health.

Profile Components

• Albumin – assessment of nutritional status and accurate interpretation of calcium levels.
• Creatinine – evaluation of kidney function.
• Total Calcium – assessment of bone metabolism.
• Phosphorus – evaluation of bone mineralization processes.
• Alkaline Phosphatase (ALP) – marker of bone remodeling activity.
• Vitamin D (25-OH) – assessment of vitamin D status and bone health.
• TSH (Thyroid-Stimulating Hormone) – evaluation of the impact of thyroid function on bone health.
• Intact Parathyroid Hormone (PTH) – assessment of mineral metabolism regulation.

Indications

• Evaluation of osteopenia and osteoporosis risk.
• Monitoring bone health in postmenopausal women and men over 50 years of age.
• Assessment of fractures resulting from minor trauma.
• Suspected vitamin D deficiency.
• Endocrine disorders affecting bone metabolism.
• Monitoring patients receiving osteoporosis treatment.

Procedure

The profile is performed using a venous blood sample collected through standard venipuncture. The procedure is quick, safe, minimally invasive, and carried out by qualified healthcare professionals.
 

Sources:

https://pmc.ncbi.nlm.nih.gov/articles/PMC5335887/
https://www.sciencedirect.com/science/article/pii/S0022316622017473
https://cemf.md/wp-content/uploads/2023/07/15573-PCN-8520Osteoporoza20la20adult.pdf
https://academic.oup.com/edrv/article/46/4/576/8104766
https://www.aafp.org/pubs/afp/issues/2022/0300/p289.html